The short answer: yes — there is a prescription weight-loss tablet available in Ireland right now, and it is called orlistat (sold as Xenical). But it is almost certainly not the pill you have been reading about. The GLP-1 pills driving the headlines — the Wegovy pill and Foundayo — are not available in Ireland yet.
That gap between "approved" and "on the shelf" confuses a lot of people. This guide sets out what you can actually get here today, what is coming, and — the part most coverage misses — why the pill Ireland is waiting for will end up being made in County Westmeath.
The weight-loss pill you can actually get in Ireland today
Orlistat, sold under the brand name Xenical, is a prescription weight-loss capsule that has been available in Ireland for years. It is licensed, regulated, and prescribed here by GPs and by online doctor services.
It works differently to the GLP-1 medicines. Rather than acting on appetite, orlistat blocks an enzyme in your gut called lipase, so some of the fat in each meal passes through undigested instead of being absorbed.
A lower-strength version (orlistat 60 mg, sold as Alli) is available without a prescription. The 120 mg prescription strength is the one a doctor assesses you for.
Who it is generally considered for
It is typically considered for adults with a BMI of 30 or above, or 28 and above alongside a weight-related condition — though eligibility is always a decision for the prescribing clinician, based on your history.
Two honest caveats, because they matter. Orlistat's average results in clinical trials are considerably more modest than those reported for GLP-1 medicines. And because it works by leaving fat undigested, its side effects are largely digestive and closely tied to how much fat is in your diet.
Whether it suits you is a conversation for a doctor, not a decision to make from an article. If you would like an Irish doctor to look at your history, you can start with a free eligibility assessment.
The Wegovy pill: approved for Ireland, but not yet supplied here
On 15 July 2026 the European Commission granted marketing authorisation for the Wegovy pill — a once-daily 25 mg oral semaglutide tablet — across every EU member state, Ireland included. It is the first GLP-1 licensed in tablet form for weight management in Europe.
And yet no Irish pharmacy can dispense it.
That is not a contradiction. It is simply how medicines reach patients. A marketing authorisation is permission to sell. It is not a supply chain, a price, or a launch date.
Novo Nordisk currently supplies the pill in the United States, the United Kingdom and the UAE, and has said it intends to launch in further countries during the second half of 2026. At the time of writing, no Irish availability date has been confirmed. We saw the same sequence with the injectable version: authorisation landed well before pharmacies here had stock and dispensing guidance.
The timeline: how the weight-loss pill reached Europe
The part most coverage misses: the Wegovy pill will be made in Athlone
In March 2026, Novo Nordisk began a €432 million investment to add a new tabletting plant at its existing 45-acre site in Athlone, County Westmeath. The stated purpose is to manufacture its oral GLP-1 medicines — including the Wegovy pill — for Ireland and the wider European market.
So the tablet Irish patients cannot currently buy is, in a real sense, an Irish product in waiting.
It does not shorten the wait on its own — building and validating pharmaceutical manufacturing capacity takes years. But it tells you something useful about intent. Companies do not spend that kind of money on a facility for a European market they do not plan to serve.
Foundayo (orforglipron): approved in the US, not in Europe
The other pill in the headlines is orforglipron, marketed as Foundayo by Eli Lilly. The US Food and Drug Administration approved it on 1 April 2026 for adults with obesity, or overweight with a weight-related condition.
Its practical appeal is convenience. Unlike oral semaglutide, which has strict instructions about food, water and timing, orforglipron is a small-molecule tablet that can be taken at any time of day without those restrictions.
In a 72-week randomised, placebo-controlled trial, participants on the highest dose who remained on treatment lost an average of about 12.4% of body weight, compared with about 0.9% on placebo. Those are trial averages, with wide variation between individuals — not a result any one person should expect.
Important for Irish readers: a US approval carries no weight here. Foundayo has not been authorised by the European Medicines Agency, so it cannot legally be prescribed or dispensed in Ireland. Anyone offering to sell it to you here is not operating within the rules.
Did you know you can claim up to 75% back on your health insurance?
See how the claim works →Why "approved" and "available" are not the same thing
It is worth understanding the steps, because it answers every "when can I get it?" question:
- Authorisation — a regulator agrees the medicine is safe and effective enough to be sold. This is what happened for the Wegovy pill in July 2026.
- Launch and supply — the manufacturer decides which markets to enter and when, and produces enough stock. GLP-1 medicines have been supply-constrained globally for years.
- Pricing and reimbursement — a price is set for the market. In Ireland, weight-loss medicines are not currently reimbursed by the HSE, so this is a private cost.
- Pharmacy availability — stock and dispensing guidance actually reach pharmacy counters.
A medicine can sit between the first and last of those steps for a long time. That is exactly where the Wegovy pill is for Ireland today.
A word of caution about "weight-loss pills" sold online
Search for weight-loss pills and most of what you will find is not medicine at all. Fat burners, slimming capsules and diet supplements are sold as food supplements, which means they are not assessed for effectiveness the way a licensed medicine is.
More seriously, there is a live market in unlicensed products sold as GLP-1 medicines. Because the real pills are unavailable in Ireland while demand is high, that gap is exactly what bad actors exploit.
Products bought this way may contain the wrong dose, the wrong ingredient, or nothing useful at all — and there is no pharmacist, no prescriber, and no recourse.
The simple test: a genuine prescription weight-loss medicine in Ireland involves a clinician who reviews your medical history before anything is prescribed. If a site is willing to sell you a GLP-1 without that, it is not a shortcut — it is a warning sign.
What is licensed and available in Ireland right now
If you are weighing up options today rather than waiting, this is the honest picture:
- Orlistat (Xenical) — a prescription capsule, available now, working by reducing fat absorption.
- Injectable GLP-1 medicines — including tirzepatide and semaglutide, available on private prescription through licensed pharmacies. These are the treatments most of the recent weight-management evidence relates to.
If you want to understand what the injectable options actually cost here, we keep a detailed breakdown in our guide to Mounjaro prices in Ireland, and a full overview of eligibility and access in the Mounjaro Ireland guide. For the two pills specifically, we track developments in our pieces on the Wegovy pill in Ireland and on Foundayo and orforglipron.
How to find out where you stand — in a few minutes
Want to know when the pill reaches Ireland?
The practical move, if you are waiting on an oral option, is to find out where you stand now. Our free assessment tells you which licensed treatments an Irish doctor would consider appropriate for you today — with no obligation to start.
It is also how you book a call with our team, so you can ask about oral options directly. You can check your eligibility here.
Weight-loss pills in Ireland: FAQ
Is there a weight-loss pill available in Ireland?
Yes. Orlistat, sold as Xenical, is a prescription weight-loss capsule available in Ireland now, and a lower 60 mg strength is sold without prescription as Alli. The newer GLP-1 pills — the Wegovy pill and Foundayo — are not available in Ireland yet.
When will the Wegovy pill be available in Ireland?
No Irish date has been confirmed. The European Commission authorised it on 15 July 2026, and it is currently supplied in the US, UK and UAE. Novo Nordisk has said it plans to launch in more countries during the second half of 2026, but authorisation and availability are separate steps.
Can I get Foundayo (orforglipron) in Ireland?
No. Foundayo was approved by the US FDA in April 2026 but has not been authorised in the European Union, so it cannot legally be prescribed or dispensed in Ireland.
Is the Wegovy pill made in Ireland?
It will be. Novo Nordisk began a €432 million expansion of its Athlone, County Westmeath site in March 2026 to add tabletting capacity for its oral GLP-1 medicines, serving Ireland and the European market. That expansion is expected to be complete by 2028.
Are weight-loss pills covered by the HSE?
Weight-loss medicines are not currently reimbursed by the HSE for weight management, and are not on the Drugs Payment Scheme or medical card list for that purpose, so they are a private cost.
Are the fat burners and diet pills sold online the same thing?
No. Those are generally sold as food supplements, not licensed medicines, and are not assessed for effectiveness in the same way. A licensed prescription weight-loss medicine in Ireland always involves a clinician reviewing your medical history first.
This article is general information about medicines available in Ireland and is not medical advice. Whether any treatment is appropriate for you is a decision for a qualified clinician who knows your medical history.
